Skip to main content

Clinical and Translational Oncology

Ausgabe 10/2023

Inhalt (28 Artikel)

REVIEW ARTICLE

The dual and multifaceted role of relaxin-2 in cancer

Louis Boafo Kwantwi

Open Access REVIEW ARTICLE

Deleted in lymphocytic leukemia 2 (DLEU2): a possible biomarker that holds promise for future diagnosis and treatment of cancer

Xue Qu, Yu-xia Cao, Yuan-xin Xing, Qi Liu, Huan-jie Li, Wei-hua Yang, Ban-qin Wang, Shu-yi Han, Yun-shan Wang

REVIEW ARTICLE

The sequestosome 1 protein: therapeutic vulnerabilities in ovarian cancer

Maryam Nurzadeh, Seyedeh Mojgan Ghalandarpoor-Attar, Seyedeh Noushin Ghalandarpoor-Attar, Maryam Rabiei

Open Access REVIEW ARTICLE

Recent advances in CAR T-cell therapy for lymphoma in China

Yuxuan Che, Xiuhua Sun

REVIEW ARTICLE

Periodontitis and progression of gastrointestinal cancer: current knowledge and future perspective

Kamyar Nasiri, Masoud Amiri Moghaddam, Enas Abdalla Etajuri, Ashkan Badkoobeh, Omid Tavakol, Mohammadamin Rafinejad, Armita Forutan Mirhosseini, Amirhossein Fathi

REVIEW ARTICLE

Emerging roles of long non-coding RNA FTX in human disorders

Mohadeseh Sheykhi-Sabzehpoush, Majid Ghasemian, Fatemeh Khojasteh Pour, Mohammad Mighani, Mehdi Moghanibashi, Razieh Mohammad Jafari, Maciej Zabel, Piotr Dzięgiel, Maryam Farzaneh, Bartosz Kempisty

REVIEW ARTICLE

LncRNA CASC19: a novel oncogene involved in human cancer

Shidong Wang, Chen Qiao, Rui Fang, Shuyue Yang, Guiping Zhao, Si Liu, Peng Li

REVIEW ARTICLE

Advances in the expression and function of Fyn in different human tumors

Changqing Liu, Shan Li, Yunlian Tang

REVIEW ARTICLE

Local treatment in oligometastasis from breast cancer: an overview

Ana Manterola Burgaleta, Andrea Barco Burguete, Lombardo Rosas Gutiérrez, Erkuden Burillo Nuín, Gemma Asín Felipe, Fernando Arias de la Vega

SPECIAL ARTICLE

Remembering Edmund Klein: the Father of Immunotherapy

Edmund Jack Janniger, Anatea Carina Einhorn, William Clark Lambert

RESEARCH ARTICLE

Effect of doramectin on programmed cell death pathway in glioma cells

Songlin Du, Hongsheng Liang, Lu Zhou, Chen Chen, Ruimeng Sun, Jie Zhang, Xiangyi Meng, Aili Gao

RESEARCH ARTICLE

Optimal cisplatin cycles in locally advanced cervical carcinoma patients treated with concurrent chemoradiotherapy

Zheng Zeng, Weiping Wang, Xiaoliang Liu, Guangyu Wang, Kang Ren, Fuquan Zhang, Ke Hu

RESEARCH ARTICLE

Hsa_circ_0001535 inhibits the proliferation and migration of ovarian cancer by sponging miR-593-3p, upregulating PTEN expression

Yuwen Han, Yanli Zheng, Jun You, Yun Han, Xiaoyan Lu, Xuan Wang, Chao Shi, Weipei Zhu

RESEARCH ARTICLE

Morbimortality after 1321 consecutive CRS + HIPEC procedures: seeking excellence in surgery for peritoneal surface malignancy

Maria Isabel Ramos Bernadó, Oriol Crusellas Maña, Montserrat Martín-Baranera, Pedro Barrios Sánchez

Open Access RESEARCH ARTICLE

Does body mass index influence surgical options and overall survival in breast cancer patients?

Carla Luís, Rute Fernandes, João Dias, Deolinda Pereira, Firmino Machado, Pilar Baylina, Rúben Fernandes, Raquel Soares

RESEARCH ARTICLE

Application value of CT-guided localization using a coil in combination with medical adhesive in sublobar resection

Shanhai Yu, Wei Li, Xiangding Liu, Xiuguo Chen, Xiaolong He, Xianling Duan, Nianxin Zhang, Zhizhong Yan, Liwei Zhang

RESEARCH ARTICLE

The involvement of PDIA2 gene in the progression of renal cell carcinoma is potentially through regulation of JNK signaling pathway

Huilong Fang, Zhonglu Peng, Bin Tan, Nan Peng, Biao Li, Dongyang He, Mingjie Xu, Zhiying Yang

Open Access RESEARCH ARTICLE

Observational study of HR+/HER2− metastatic breast cancer patients treated with abemaciclib in Spain in the Named Patient Use Program (AbemusS)

Salvador Blanch, Juan Miguel Gil-Gil, Miriam Arumí, Elena Aguirre, Miguel Ángel Seguí, Manuel Atienza, Silvia Díaz-Cerezo, Alberto Molero, José Manuel Cervera, Joaquín Gavilá

RESEARCH ARTICLE

miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2

Hao-Tian Liu, Cheng-Piao Luo, Meng-Jie Jiang, Zhu-Jian Deng, Yu-Xian Teng, Jia-Yong Su, Li-Xin Pan, Liang Ma, Ping-Ping Guo, Jian-Hong Zhong

RESEARCH ARTICLE

DC vaccine enhances CAR-T cell antitumor activity by overcoming T cell exhaustion and promoting T cell infiltration in solid tumors

Miaomiao Zhang, Yuanyuan Wang, Xinzu Chen, Fan Zhang, Jiannan Chen, Hongqiao Zhu, Jun Li, Zhengliang Chen, Aying Wang, Yao Xiao, Zilu Chen, Yunfei Dong, Xuechen Yin, Feng Ji, Jie Liu, Junqing Liang, Feiyan Pan, Zhigang Guo, Lingfeng He

RESEARCH ARTICLE

Improving the diagnosis of myelodysplastic syndrome by red blood cell parameters

Ying Zhu, Suyang Han, Xue Chen, Sanyun Wu, Bei Xiong

RESEARCH ARTICLE

Aging-related genes related to the prognosis and the immune microenvironment of acute myeloid leukemia

Dongxu Gang, Yinyan Jiang, Xiaofang Wang, Jifan Zhou, Xiaoyuan Zhang, Xiaoyu He, Rujiao Dong, Ziyang Huang, Songfu Jiang

RESEARCH ARTICLE

The development of radioresistant oral squamous carcinoma cell lines and identification of radiotherapy-related biomarkers

Junhong Huang, Qingzhe Meng, Rong Liu, Huan Li, Yahui Li, Zihui Yang, Yan Wang, Chaojie Wanyan, Xinjie Yang, Jianhua Wei

Open Access RESEARCH ARTICLE

Immune checkpoint inhibitor-associated thrombosis in patients with bladder and kidney cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group

Manuel Sánchez Cánovas, David Fernández Garay, Evdochia Adoamnei, Esperanza Guirao García, Javier López Robles, Diego Cacho Lavin, Eva Martínez de Castro, Begoña Campos Balea, Alberto Garrido Fernández, Isaura Fernández Pérez, Asia Ferrández Arias, Noelia Suarez, Teresa Quintanar Verduguez, Miriam Lobo de Mena, Laura Rodríguez, David Gutierrez, Ana Manuela Martín Fernández de Soiginie, Silvia García Adrián, Ana Isabel Ferrer Pérez, María Jesús Delgado Heredia, Amelia Muñoz Lerma, Raquel Luque, Manuel Mazariegos Rubí, Ana Belen Rúperez Blanco, Ignacio García Escobar, Jaime Mendiola, Andrés Jesús Muñoz Martín

Open Access RESEARCH ARTICLE

Anti-PD-1 immunotherapy with dose-adjusted ultra-hypofractionated re-irradiation in patients with locoregionally recurrent head and neck cancer

Ioannis M. Koukourakis, Axiotis G. Giakzidis, Michael I. Koukourakis

Open Access RESEARCH ARTICLE

Oncogenic roles of GPR176 in breast cancer: a potential marker of aggressiveness and a potential target of gene therapy

Wen-jing Yun, Hang Xue, Ning Yang, Li-jun Xiao, Hong-zhi Sun, Hua-chuan Zheng

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.